2022

Brisebarre et al, 2022

Brisebarre A, Ancel J, Ponchel T, Loeffler E, Germain A, Dalstein V, Dormoy V, Durlach A, Delepine G, Deslée G, Polette M, Nawrocki-Raby B. Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer. Front Immunol. 2022 Dec 5;13:1058531. doi: 10.3389/fimmu.2022.1058531. PMID: 36544755; PMCID: PMC9760670.


L'unité UMR-S 1250 unit est un partenaire du PRC IRUPP (IRon Uptake Pathways in Pseudomonas aeruginosa: phenotypic switches and mechanism of regulation) à l'AAPG 2022.

ANR

Luczka et al, 2022

Luczka-Majérus E, Bonnomet A, Germain A, Lalun N, Kileztky C, Perotin JM, Deslée G, Delepine G, Polette M, Dormoy V, Coraux C. Ciliogenesis is intrinsically altered in COPD small airways. Eur Respir J. 2022 Dec 22;60(6):2200791. doi: 10.1183/13993003.00791-2022. PMID: 36396143; PMCID: PMC9772502.


Saber-Chérif et al, 2022

Saber Cherif L, Diabasana Z, Perotin JM, Ancel J, Petit LMG, Devilliers MA, Bonnomet A, Lalun N, Delepine G, Maskos U, Gosset P, Polette M, Muggeo A, Guillard T, Deslée G, Dormoy V. The Nicotinic Receptor Polymorphism rs16969968 Is Associated with Airway Remodeling and Inflammatory Dysregulation in COPD Patients. Cells. 2022 Sep 20;11(19):2937. doi: 10.3390/cells11192937. PMID: 36230899; PMCID: PMC9563397.


L’unité UMR-S 1250 est partenaire du PRC iREG2 (Immune regulation regeneration) à l’AAPG 2022.

ANR

Babosan et al, 2022

Babosan A, Skurnik D, Muggeo A, Pier GB, Baharoglu Z, Jové T, Ploy MC, Griveau S, Bedioui F, Vergnolle S, Moussalih S, de Champs C, Mazel D, Guillard T. A qnr-plasmid allows aminoglycosides to induce SOS in Escherichia coli. Elife. 2022 Jan 17;11:e69511. doi: 10.7554/eLife.69511. PMID: 35037621; PMCID: PMC8789287


L’unité UMR-S 1250 est coordinatrice du PRME STarCilOPD (Screening and targeting of cilia defects in chronic obstructive pulmonary disease) à l’AAPG 2022.

ANR

Perotin et al, 2022

Perotin JM, Gierski F, Bolko L, Dury S, Barrière S, Launois C, Dewolf M, Chouabe S, Bongrain E, Picard D, Tran E, N'Guyen Y, Mourvillier B, Servettaz A, Rapin A, Marcus C, Lebargy F, Kaladjian A, Salmon JH, Deslee G. Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19. Respir Res. 2022 Aug 2;23(1):199. doi: 10.1186/s12931-022-02111-9. PMID: 35918719; PMCID: PMC9344257.